Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris.
In order to investigate whether products derived from the oxidation of sebum can be responsible for the induction of inflammatory processes, HaCaT keratinocytes were treated with peroxidated squalene. NF-kappaB activation, secretion, and expression of IL-6, as well as peroxisome proliferator-activated receptor alpha (PPARalpha) mRNA and protein levels, were measured at the end of the treatment and after 24 and 48 hours of recovery. Squalene peroxidation products were administered in amounts able to elicit significant hyperproliferation and to induce lipoxygenase (LOX) activity. The results showed an early activation of NF-kappaB followed by an increase in PPARalpha mRNA and protein levels. Moreover, squalene peroxides induced an initial upregulation of IL-6 production and secretion that was counteracted by PPARalpha activation, as suggested by the subsequent decrease of NF-kappaB nuclear translocation and IL-6 levels. Inflammatory processes play an important role in the development of acne vulgaris. In combination with our own previous findings, which indicated an association between LOX stimulation and increased percentage of proinflammatory lipids in acne as well as a correlation between increased cytokine levels in the infundibulum, pilosebaceous duct hyperkeratinization, and augmented sebogenesis, the present data further support the involvement of lipid peroxides, in particular squalene peroxides, in establishing an inflammatory process in acne.
Ottaviani
Monica
M
San Gallicano Dermatological Institute IRCCS, Rome, Italy.
Alestas
Theodosis
T
Flori
Enrica
E
Mastrofrancesco
Arianna
A
Zouboulis
Christos C
CC
Picardo
Mauro
M
D000152:Acne Vulgaris / Q000209:etiology* / Q000378:metabolism; D002460:Cell Line; D049109:Cell Proliferation; D006801:Humans; D015850:Interleukin-6 / Q000235:genetics / Q000378:metabolism*; D015603:Keratinocytes / Q000187:drug effects / Q000378:metabolism*; D050356:Lipid Metabolism; D015227:Lipid Peroxidation; D008084:Lipoxygenase / Q000378:metabolism; D016328:NF-kappa B / Q000235:genetics / Q000378:metabolism*; D047493:PPAR alpha / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D012629:Sebum / Q000378:metabolism; D013185:Squalene / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D015854:Up-Regulation
C002821:2,3-oxidosqualene; D015850:Interleukin-6; D016328:NF-kappa B; D047493:PPAR alpha; D012333:RNA, Messenger; D013185:Squalene; D008084:Lipoxygenase